Innovation and Translational Stem Cell Therapy for Diabetes and Neurological Diseases: Paving the way for real life solutions Post author: Post published: November 17, 2026 Post category: Continue ReadingInnovation and Translational Stem Cell Therapy for Diabetes and Neurological Diseases: Paving the way for real life solutions
2012 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research Post author: Post published: November 17, 2026 Post category: Continue Reading2012 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research
2011 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research Post author: Post published: November 17, 2026 Post category: Continue Reading2011 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research
2013 Rachmiel Diabetes and Obesity Levine Symposium – Advances in Diabetes Research Post author: Post published: November 17, 2026 Post category: Continue Reading2013 Rachmiel Diabetes and Obesity Levine Symposium – Advances in Diabetes Research
2009 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Biology, Immunology and Cell Therapy Post author: Post published: November 17, 2026 Post category: Continue Reading2009 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Biology, Immunology and Cell Therapy
Advancing ISP-001 for Mucopolysaccharidosis I: Clinical Expansion, Clinical Manufacturing and Release Testing Post author: Post published: November 16, 2026 Post category: Continue ReadingAdvancing ISP-001 for Mucopolysaccharidosis I: Clinical Expansion, Clinical Manufacturing and Release Testing
A Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type 1 and Advancing ISP-001 for Mucopolysaccharidosis I: Clinical Expansion, Clinical Manufacturing and Release Testing Post author: Post published: November 16, 2026 Post category: Continue ReadingA Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type 1 and Advancing ISP-001 for Mucopolysaccharidosis I: Clinical Expansion, Clinical Manufacturing and Release Testing
Decoding Human Pancreatic Progenitor Biology to Enable Next-Generation Stem Cell-based Therapies for Type 1 Diabetes Post author: Post published: November 16, 2026 Post category: Continue ReadingDecoding Human Pancreatic Progenitor Biology to Enable Next-Generation Stem Cell-based Therapies for Type 1 Diabetes
Impact of Sex-Differences on Intestinal Stem Cell Function in Pediatric Inflammatory Bowel Disease Post author: Post published: November 16, 2026 Post category: Continue ReadingImpact of Sex-Differences on Intestinal Stem Cell Function in Pediatric Inflammatory Bowel Disease
Hypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes Post author: Post published: November 16, 2026 Post category: Continue ReadingHypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes